Emerging MedTech Capital

www.medtechvp.com

VCMatch tracks Emerging MedTech Capital as an investor focused on Medtech, Digital Health, and AI/ML companies, Seed and Series A rounds, and United States, San Francisco Bay Area, and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Medtech, Digital Health, AI/ML

Geography

United States, San Francisco Bay Area, and Global

Investment Thesis

MedTech Venture Partners focuses on investing in and actively supporting early-stage medical device entrepreneurs, leveraging deep operating, clinical and regulatory experience to accelerate product development and commercialization. The firm emphasizes hands-on partnership (not just capital), applying experience from scaling companies, operating large device businesses, and participating in transactions to improve founder outcomes and exits.

Is Emerging MedTech Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Emerging MedTech Capital is most relevant for founders raising Seed and Series A rounds in Medtech, Digital Health, AI/ML, and Data Infrastructure, especially across United States, San Francisco Bay Area, and Global.

Focus statement

“A focus on device entrepreneurs.” The firm states plainly that “we fund and support medical technology entrepreneurs,” with particular emphasis on early-stage medical devices and diagnostics and building an ecosystem with academic partners (UCSF) to support commercialization.

Value Add

Proven device operating experience: the site says the team has “overseen the conception, development, and launch of over 30 medical devices and diagnostics products.”
Deep clinical and regulatory expertise: the firm highlights “extensive clinical and regulatory experience globally,” reflected in team bios and clinical advisors.
Strong industry and academic network: explicit partnership with UCSF — “Together with our partners at UCSF we are building an exciting ecosystem around early stage medical devices.”
Senior executive leadership and advisor bench: partners and advisors include former CEOs and senior execs from Grifols, Gambro, Baxter, Siemens, Merck, and prominent investors/advisors such as Brook Byers and Casey McGlynn.
Track record of exits and acquisitions in portfolio: multiple portfolio entries note exits or acquisitions (e.g., “[acquired by Laborie]”, “[acquired by Zimmer]”, and other “acquired” notes).